Novo Holdings REPAIR Impact Fund issues fresh proposal call
Denmark-based Novo Holdings REPAIR Impact Fund has announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance. The submission period will run from 1 April to 7 May, 2021.
This is the €135 million ($165 million) REPAIR Impact Fund's sixth call for investment proposals since it was set up in 2018, and second global call. To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis. REPAIR provides not only funding, but also critical strategic support and connections to other investors to accelerate the development of early-stage novel antibiotics towards the clinic.
The REPAIR Impact Fund initially invests only in projects that are between lead optimization and Phase 1 clinical trials; however, the Fund may continue to support its portfolio companies as they advance into Phase 2 clinical trials.
